Perioperative Cystoscopy and Methylene Blue Test: The ability of perioperative methylene blue and cystoscopy versus postoperative cystoscopy to detect complications will be compared in patients.
Study summary
Comparison of complications detected by perioperative cystoscopy combined with methylene blue test and postoperative cystoscopy in TVT and TOT operations.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
85 Years
Healthy volunteers
No
Inclusion Criteria:
* Providing consent to participate in the study
* Being between the ages of 18 and 85
* Having stress urinary incontinence
* No active cardiac disease
* No connective tissue disorders (e.g., Marfan syndrome)
* No known gynecological malignancy
* BMI under 30
* No chronic constipation
* No inflammatory bowel disease
Exclusion Criteria:
* Not providing consent to participate in the study
* Being under 18 or over 85 years old
* Not having stress urinary incontinence
* Having active cardiac disease
* Having connective tissue disorders (e.g., Marfan syndrome)
* Having a known gynecological malignancy
* Having a BMI over 30
* Having chronic constipation
* Having inflammatory bowel disease
Primary outcome measure(s)
rate of complication detection — 6 months Specifically, it would compare the ability of the perioperative methylene blue test and cystoscopy versus postoperative cystoscopy to detect complications. This measure will be used to evaluate the accuracy and effectiveness of both methods
Trial sites (1)
Facility
City
Region
Status
Gaziosmanpaşa Training and Research Hospital
Istanbul
Turkey (Türkiye)
Recruiting
More Gaziosmanpasa Research and Education Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.